MDT
Medtronic plc
September 14, 2026 · pre-market
- Rarity
- 1.13
- Peak move
- +3.94%
- Float cap
- $116.4B
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, and patients. Its product portfolio spans cardiovascular rhythm and heart failure devices, structural heart and aortic valves, and medical-surgical equipment across neuroscience and surgical care. Medtronic operates in more than 150 countries.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
5 events · 0 from SEC or newswire · 3 timed with the move- Key eventTimed with the move
spinoff_divestitureMedtronic commenced an exchange offer to split off at least 80.1% of MiniMed Group (Nasdaq: MMED), letting holders swap Medtronic ordinary shares for up to 225,361,295 MiniMed shares at a 7% discount, capped at 4.5939 MiniMed shares per Medtronic share, with the offer expiring October 9, 2026.
- Key eventTimed with the move
executive_remarkMedtronic Chairman and CEO Geoff Martha said the MiniMed exchange offer launch reflects confidence in MiniMed as a standalone company and lets Medtronic focus capital allocation on its Cardiovascular, Neuroscience and Surgical portfolios.
- Timed with the move
analyst_ratingWells Fargo analyst Larry Biegelsen maintained a Buy rating on Medtronic with a $114.00 price target.
- Key event
shelf_registrationMiniMed Group filed a Form S-4 registration statement with the SEC covering Medtronic's exchange offer of up to 225,361,295 MiniMed shares (80.1% of its stock), after which Medtronic would hold no stake; Medtronic also filed a Schedule TO tender offer statement, and the offer requires at least 112,680,647 MiniMed shares issued and a tax-free opinion.
institutional_flowNewEdge Advisors LLC cut its Medtronic (MDT) position by 18.9% in the second quarter, selling 34,627 shares to hold 148,741 shares worth about $11.6 million as of its latest SEC filing.